Assessment of Seroconversion after SARS-CoV-2 Vaccination in Patients with Lung Cancer

Background: SARS-CoV-2 mortality rates are significantly higher in patients with lung cancer compared with the general population. However, little is known on their immunization status after vaccination. Methods: To evaluate the humoral response (seroconversion) of patients with lung cancer followin...

Descripción completa

Detalles Bibliográficos
Autores principales: Trontzas, Ioannis P., Vathiotis, Ioannis, Economidou, Christina, Petridou, Ioulia, Gomatou, Georgia, Grammoustianou, Maria, Tsamis, Ioannis, Syrigos, Nikolaos, Anagnostakis, Maximilian, Fyta, Eleni, Sakka, Vissaria, Poulakou, Garyphalia, Kotteas, Elias A., Syrigou, Ekaterini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031406/
https://www.ncbi.nlm.nih.gov/pubmed/35455367
http://dx.doi.org/10.3390/vaccines10040618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031406/
https://www.ncbi.nlm.nih.gov/pubmed/35455367
http://dx.doi.org/10.3390/vaccines10040618

Ejemplares similares